TITLE

Short-term clopidogrel recommended by UK NICE

PUB. DATE
August 2004
SOURCE
PharmacoEconomics & Outcomes News;8/14/2004, Issue 459, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on the guidance issued by the British National Institute for Clinical Excellence to the National Health Service in England and Wales for the use of clopidogrel in the treatment of non-ST-segment elevation acute coronary syndrome. Recommendations on the use of clopidogrel; Duration of clopidogrel therapy.
ACCESSION #
14934841

 

Related Articles

  • CR oxycodone cost study biased?  // PharmacoEconomics & Outcomes News;8/28/2004, Issue 460, p2 

    Refutes a study assessing the economic implications of long-acting opioid switching. Claims of Pontus Jaderholm from Kaiser Permanente Medical Center in Portland, Oregon, on the difference in healthcare charges between the therapies studied and switching opioid therapy; Criticism against the...

  • Short-term clopidogrel recommended by UK NICE.  // PharmacoEconomics & Outcomes News;8/14/2004, Issue 459, p2 

    Reports on the guidance issued by the British National Institute for Clinical Excellence to the National Health Service in England and Wales for the use of clopidogrel in the treatment of non-ST-segment elevation acute coronary syndrome. Recommendations on the use of clopidogrel; Duration of...

  • Short-term clopidogrel recommended by UK NICE.  // PharmacoEconomics & Outcomes News;8/14/2004, Issue 459, p2 

    Reports on the guidance issued by the British National Institute for Clinical Excellence to the National Health Service in England and Wales for the use of clopidogrel in the treatment of non-ST-segment elevation acute coronary syndrome. Recommendations on the use of clopidogrel; Duration of...

  • Simvastatin over the counter: a prescribing controversy. Chowdhury, Shefali // Nurse Prescribing;Jun2005, Vol. 3 Issue 3, p94 

    The article discusses the controversies related to over-the-counter (OTC) prescribing of simvastatin. Simvastatin lower overall cardiovascular morbidity and mortality in coronary heart diseases adult patients so OTC simvastatin may be considered a public health opportunity. However, the issue of...

  • Costs of a community pharmacist-led medicines management service for patients with coronary heart disease in England: healthcare system and patient perspectives. Scott, Anthony; Tinelli, Michela; Bond, Christine; Community Pharmacy Medicines Management Evaluation Team // PharmacoEconomics;2007, Vol. 25 Issue 5, p397 

    Background: Coronary heart disease (CHD) is the most common cause of death in the UK. CHD cost the UK National Health Service (NHS) pound 3.5 billion in 2003. The economic impact of community pharmacists providing a medicines management service for patients with CHD has not been...

  • Generic simvastatin switch could save UK NHS £2 billion.  // PharmacoEconomics & Outcomes News;6/17/2006, Issue 505, p3 

    The article reports on the claim of doctors James C. Moon and Richard G. Bogle that the Great Britain National Health Services (NHS) can save money by prescribing generic simvastatin instead of atorvastatin to patients requiring primary prevention of coronary disorders. They said that the switch...

  • Heart failure now on the palliative care agenda. Addington-Hall, J.; Gibbs, J. // Palliative Medicine;Sep2000, Vol. 14 Issue 5, p361 

    Comments on the April 2000 publication of National Service Frameworks (NSF) for coronary heart disease (CHD), as part of the modernization program of Great Britain's National Health Service. Commendation of the NSF authors for recognizing that palliative care may benefit CHD patients; Value of...

  • Advisory committee on selected list of drugs.  // British Medical Journal (Clinical Research Edition);7/20/1985, Vol. 291 Issue 6489, p230 

    Reports the setting up of an advisory committee to review the selected list of National Health Service drugs in Great Britain. List of drugs in the committee; Priorities of the committee; Details on the code of good practice for radiology services and private patients.

  • Increase in alcohol dependency drugs.  // PRWeek (London);6/4/2010, p6 

    The article focuses on a report from the British National Health Service (NHS) Information Centre on the increase in the number of prescription drugs such as Acamprosate Calcium and Disulfiram that were provided to patients for alcohol dependency treatment in England in 2009.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics